Evidence from giant cell tumour and glioma cells, small cell lung cancer and melanoma indicate that IL-1B induces proliferation of new blood vessels in vivo and that these activities are mediated indirectly via IL-1B effects on other cell types, including fibroblasts and immune cells in the tumour microenvironment [10–11]. Here, IL1B is linked to melanoma.